AZM 475271 from Tocris Bioscience, a Bio-Techne Brand | Biocompare.com

Supplier Images

AZM 475271

Src tyrosine kinase inhibitor

Be the first to write a review!

Citations:

Supplier Page from
Tocris Bioscience, a Bio-Techne Brand for
AZM 475271

Description

Src tyrosine kinase inhibitor

Product Specs
ItemAZM 475271
CompanyTocris Bioscience, a Bio-Techne Brand
Price $303.00Supplier Page View Company Product Page
Catalog Number3963/10
Quantity10 mg (also 50 mg)
Purity98%
Molecular Weight442.94
Molecule NameN-(2-Chloro-5-methoxyphenyl)-6-methoxy
FormulaC23H27ClN4O3
StorageStore at RT

Specifications/Features

Sizes Available: 10 mg (also 50 mg)

Add to Compare List

Tocris Bioscience, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956
Fax: 1 (612) 656-4400

Company Profile

Website: http://www.tocris.com

(1) Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential 'Seed' and 'Soil' Receptor in the Peritoneal Metastasis of Gastrointestinal CancersInternational journal of molecular sciencesJanuary 3, 2023Yang YM, Ye L, Ruge F, Fang Z, Ji K, Sanders AJ, Jia S, Hao C, Dou QP, Ji J, et al.

(2) Smooth muscle contraction and growth of stromal cells in the human prostate are both inhibited by the Src family kinase inhibitors, AZM475271 and PP2British journal of pharmacologyDecember 1, 2016Wang Y, Gratzke C, Tamalunas A, Rutz B, Ciotkowska A, Strittmatter F, Herlemann A, Janich S, Waidelich R, Liu C, et al.

(3) Tryptophan hydroxylase 1 and 5-HT₇ receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signalingMolecular cancerNovember 21, 2016Gautam J, Banskota S, Regmi SC, Ahn S, Jeon YH, Jeong H, Kim SJ, Nam TG, Jeong BS, Kim JA.

(4) IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cellsOncotargetAugust 16, 2016Merrouche Y, Fabre J, Cure H, Garbar C, Fuselier C, Bastid J, Antonicelli F, Al-Daccak R, Bensussan A, Giustiniani J.

(5) Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancerScientific reportsMay 14, 2015Thakur R, Trivedi R, Rastogi N, Singh M, Mishra DP.

(6) Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repairThe Journal of clinical investigationJanuary 1, 2013Leoni G, Alam A, Neumann PA, Lambeth JD, Cheng G, McCoy J, Hilgarth RS, Kundu K, Murthy N, Kusters D, et al.

Be the First to Write a Review!